Tools
Stock profile

Medpace Holdings, Inc. (MEDP)

MEDP · Latest close $646.87 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$646.87
As of Nov 18, 2026
Tracked funds holding
5 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
4
vs previous quarter

Medpace Holdings, Inc. (MEDP) is held by 5 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 4 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $191.8M sold). 1 member of Congress reported 2 purchases vs 0 sales. Latest close $646.87 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Oct 29, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-191.8M
Congress
2 buys vs 0 sales
Fundamentals
Revenue · FY2025
Red flags
screens flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Giverny Capital · Vulcan Value Partners · Mairs & Power Funds — 5 tracked funds hold MEDP. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 25 sales ($191.8M). Insider trading 1 member of Congress reported buying (2 purchases vs 0 sales). Latest buy: May 15, 2026. Politician trading

Often held alongside

BADGER METER INC (BMI) · AUTOMATIC DATA PROCESSING INC (ADP) · VEEVA SYSTEMS INC (VEEV) · LITTELFUSE INC /DE (LFUS) · TJX COMPANIES INC /DE/ (TJX) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Giverny Capital4.52%253,931TRIMMED (-0.8%) Q3 filed Nov 12
Vulcan Value Partners2.28%141,743TRIMMED (-30.2%) Q3 filed Nov 10
Mairs & Power Funds0.42%86,715ADDED (+1.2%) Q3 filed Nov 16
Fundsmith0.20%52,372TRIMMED (-16.4%) Q3 filed Nov 16
PineStone Asset Management0.01%1,760TRIMMED (-33.3%) Q3 filed Oct 16

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +20.2% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

692.68260.612024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding690 of 8,857 filers
Long-only filers among them688
Change vs 2026 Q1-25 net · 638 entered · 663 exited
Shares reported, all filers24,528,825
Reported value, all filers$11.4B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryServices-Commercial Physical & Biological Research (SIC 8731)
Revenue · FY2025$2.5B
Net income · FY2025$451.1M
Total assets · FY2025$2.0B
Shares outstanding27,971,686
Market cap (at latest close)$18.1B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 16, 2026.

Short interest

Shares short · Oct 15, 20261,612,486
Share of shares outstanding5.76%
Days to cover6.59

Shares short at recent settlements — Jul 31, 2026: 1.7M · Aug 14, 2026: 1.6M · Aug 31, 2026: 1.7M · Sep 15, 2026: 1.7M · Sep 30, 2026: 1.6M · Oct 15, 2026: 1.6M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 16, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 3 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 16, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 25 sales by 7 insiders ($191.8M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Oct 29, 2026EWALD STEPHEN PGeneral Counsel & Corp. Secy.Sell1,245$690.00$859.0KSEC filing
Oct 27, 2026BURWIG SUSAN EExec. VP, OperationsSell3,940$677.00$2.7MSEC filing
Oct 26, 2026BURWIG SUSAN EExec. VP, OperationsSell16,060$677.00$10.9MSEC filing
Sep 30, 2026Troendle August J.President & CEOSell21,966$625.47$13.7MSEC filing
Sep 29, 2026Troendle August J.President & CEOSell26,701$621.02$16.6MSEC filing
Sep 28, 2026Troendle August J.President & CEOSell2,410$620.07$1.5MSEC filing
Sep 25, 2026Troendle August J.President & CEOSell154$620.60$95.6KSEC filing
Sep 24, 2026Troendle August J.President & CEOSell27,833$621.33$17.3MSEC filing
Sep 23, 2026Troendle August J.President & CEOSell16,083$628.64$10.1MSEC filing
Sep 22, 2026Troendle August J.President & CEOSell49,018$628.11$30.8MSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 26, 2026Kraft Robert O.Director3,858$2.4MAug 26, 2026SEC filing
Aug 20, 2026Brady Kevin M.Officer3,400$2.1MAug 20, 2026SEC filing
Aug 19, 2026Carley Brian TDirector5,000$3.0MAug 19, 2026SEC filing
Aug 19, 2026DAVENPORT FRED B JRDirector7,283$4.4MAug 19, 2026SEC filing
Aug 11, 2026McCarthy Cornelius P. IIIDirector1,140$690.1KAug 11, 2026SEC filing
Aug 7, 2026McCarthy Cornelius P. IIIDirector795$465.1KAug 7, 2026SEC filing
Jul 29, 2026GEIGER JESSE JFormer Officer11,000$7.0MJul 23, 2026SEC filing
Jul 28, 2026BURWIG SUSAN EOfficer7,500$4.5MJul 28, 2026SEC filing
Jul 28, 2026GEIGER JESSE JFormer Officer4,000$2.4MJul 28, 2026SEC filing
Jul 27, 2026August J. TroendleChairman307,959$184.8MJul 27, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

Activist disclosure · Schedule 13D

FiledFormPrice change since disclosure
Sep 28, 2026SCHEDULE 13D/A+5.0% (close Sep 29, 2026 → Nov 17, 2026)

Reference close is the first trading day after the filing (Sep 29, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Sep 28, 2026August J. TroendleSC 13D/A5,396,50819.1%Sep 24, 2026SEC filing
Aug 14, 2026T. Rowe Price Associates, Inc.SC 13G2,069,6797.2%Jun 30, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Dec 1, 2025August J. TroendleSC 13D/A5,682,93420.0%Nov 26, 2025SEC filing
Mar 11, 2025August J. TroendleSC 13D/A6,018,30819.5%Mar 7, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

1 member of Congress reported buying (2 purchases vs 0 sales). Bought by Republicans. Latest buy: May 15, 2026.

Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.

Recent activity by member

MemberChamberPartyBuysSellsLatestAmount range
Taylor, David J.HouseR20May 15, 2026$1,001 - $15,000

Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.

Committee jurisdiction

Industry: Services-Commercial Physical & Biological Research (SIC 8731). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Politicians

· Bought by Members — Last 6 months: bought by a member of the U.S. Congress

Financial Screens

· Growth — Revenue up every year for 5 straight years

· O'Neil CAN SLIM — Explosive earnings growth leaders

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Red Flags

· Distress Risk (Altman Z″) — Altman Z″-Score below 1.10

Key figures

· Growth — Latest revenue: $2.5B · 5-yr revenue CAGR: 22.3% · Straight growth years: 9

· O'Neil CAN SLIM — 3-yr EPS growth: 28.0% · ROE: 98.3% · Latest revenue growth: 20.0%

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.54 · Operating cash flow: $713.2M · Net income: $451.1M

· Shareholder Yield — Shareholder yield: 4.6% · of which dividends: 0.0% · of which buybacks: 4.6%

· Bought by Members — Members buying: 1 · Buy txns: 2 · Sell txns: 0 · Latest buy: May 15, 2026

· Distress Risk (Altman Z″) — Z″-Score: 0.20 · Working capital / assets: -0.18 · Retained earnings / assets: -0.23 · EBIT / assets: 0.27 · Equity / liabilities: 0.30

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2022 Q3, ranked #35 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together30.0%-13.0%+2.9%-15.9%
Share count tripled (3x)1100.0%+49.8%+8.6%+41.2%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold MEDP — ranked by lift, the co-holding pattern described in Methodology: BADGER METER INC (BMI) · AUTOMATIC DATA PROCESSING INC (ADP) · VEEVA SYSTEMS INC (VEEV) · LITTELFUSE INC /DE (LFUS) · TJX COMPANIES INC /DE/ (TJX) · ANALOG DEVICES INC (ADI).

Recent 8-K filings

FiledItemsSource
Oct 21, 20262.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing
Jul 22, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Jun 4, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain OfficersSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

BADGER METER INC (BMI) · Track Record: how the signals scored · Practice timing on MEDP

One email a week: the week’s new filings and research. Subscribe free

← MEC  ·  MELI →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.